Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Influenza Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The global influenza diagnostics market size reached US$ 828.8 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 1,237.54 Million by 2027, exhibiting a growth rate (CAGR) of 6.70% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Influenza, or flu, refers to a viral infection that mainly affects the human respiratory system, including the nose, throat, and lungs. Influenza diagnostics includes numerous immunoassay tests that aid in detecting the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens. Some of the commonly available diagnostic tests include rapid antigen testing, reverse transcription polymerase chain reaction (RT-PCR), immunofluorescence assays, serology, and rapid molecular assays. Healthcare facilities can assess the precision of these tests by looking at their sensitivity and specificity, which are crucial factors that determine their accuracy levels.

Influenza Diagnostics Market Trends:

The elevating prevalence of several chronic diseases, such as asthma, chronic obstructive pulmonary disease (COPD), bronchiectasis, cystic fibrosis, etc., that increase the risk of influenza, is primarily driving the global influenza diagnostics market. Besides this, the expanding geriatric population, who are more prone to respiratory tract infections, is also catalyzing the market growth. Additionally, the rising availability of advanced diagnostic immunoassay formats along with the growing usage of miniaturized devices in influenza diagnostics is positively influencing the global market. Moreover, the introduction of CLIA-waived POC molecular influenza tests and the shifting consumer preferences from centralized laboratories to decentralized point-of-care testing are also augmenting the market growth. In addition to this, the emerging popularity of rapid influenza diagnostic test (RIDT) that are convenient to use and provide results in approximately fifteen minutes is acting as a significant growth-inducing factor. Furthermore, various initiatives by WHO to strengthen influenza surveillance, monitoring, and data utilization, are also stimulating the market growth. In line with this, numerous government bodies are becoming more actively involved in taking preventative steps to reduce the risk of influenza. For instance, the U.S. CDC and the South-East Asian Region (SEAR) have collaborated to support non-researched bilateral influenza as a response to avian, seasonal, and pandemic influenza. In the coming years, the growing integration of artificial intelligence (AI) in influenza diagnostics to minimize the timelines for sample processing and facilitate error-free results is expected to drive the global influenza diagnostics market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global influenza diagnostics market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, test type, type of flu and end user.

Breakup by Product:

  • Test Kit and Reagents
  • Instruments
  • Others
     

Breakup by Test Type:

  • Molecular Diagnostic Tests
    • Polymerase Chain Reaction
    • Isothermal Nucleic Acid Amplification Tests
    • Other Molecular Tests
  • Traditional Diagnostic Tests
    • Rapid Influenza Diagnostic Tests
    • Viral Culture Tests
    • Direct Fluorescent Antibody Test
    • Serological Tests
       

Breakup by Type of Flu:

  • Type A Flu
  • Type B Flu
  • Type C Flu
     

Breakup by End User:

  • Hospitals
  • Diagnostic Laboratories
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Becton Dickinson and Company, Coris Bioconcept, Danaher Corporation, DiaSorin S.p.A., F. Hoffmann-La Roche Ltd (Roche Holding AG), Hologic Inc., Meridian Bioscience Inc., Qiagen N.V, Quidel Corporation, Sekisui Diagnostics LLC (Sekisui Medical Co. Ltd.) and Siemens Healthineers AG (Siemens AG).

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
    Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Million
Segment Coverage Product, Test Type, Type of Flu, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Abbott Laboratories, Becton Dickinson and Company, Coris Bioconcept, Danaher Corporation, DiaSorin S.p.A., F. Hoffmann-La Roche Ltd (Roche Holding AG), Hologic Inc., Meridian Bioscience Inc., Qiagen N.V, Quidel Corporation, Sekisui Diagnostics LLC (Sekisui Medical Co. Ltd.) and Siemens Healthineers AG (Siemens AG).
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global influenza diagnostics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global influenza diagnostics market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the test type?
  • What is the breakup of the market based on the type of flu?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global influenza diagnostics market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Influenza Diagnostics Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Product
    6.1    Test Kit and Reagents
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Instruments
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Others
        6.3.1 Market Trends
        6.3.2 Market Forecast
7    Market Breakup by Test Type
    7.1    Molecular Diagnostic Tests
        7.1.1 Market Trends
        7.1.2 Key Segments
           7.1.2.1 Polymerase Chain Reaction
           7.1.2.2 Isothermal Nucleic Acid Amplification Tests
           7.1.2.3 Other Molecular Tests
        7.1.3 Market Forecast
    7.2    Traditional Diagnostic Tests
        7.2.1 Market Trends
        7.2.2 Key Segments
           7.2.2.1 Rapid Influenza Diagnostic Tests
           7.2.2.2 Viral Culture Tests
           7.2.2.3 Direct Fluorescent Antibody Test
           7.2.2.4 Serological Tests
        7.2.3 Market Forecast
8    Market Breakup by Type of Flu
    8.1    Type A Flu
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Type B Flu
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Type C Flu
        8.3.1 Market Trends
        8.3.2 Market Forecast
9    Market Breakup by End User
    9.1    Hospitals
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Diagnostic Laboratories
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Others
        9.3.1 Market Trends
        9.3.2 Market Forecast
10    Market Breakup by Region
    10.1    North America
        10.1.1 United States
           10.1.1.1 Market Trends
           10.1.1.2 Market Forecast
        10.1.2 Canada
           10.1.2.1 Market Trends
           10.1.2.2 Market Forecast
    10.2    Asia-Pacific
        10.2.1 China
           10.2.1.1 Market Trends
           10.2.1.2 Market Forecast
        10.2.2 Japan
           10.2.2.1 Market Trends
           10.2.2.2 Market Forecast
        10.2.3 India
           10.2.3.1 Market Trends
           10.2.3.2 Market Forecast
        10.2.4 South Korea
           10.2.4.1 Market Trends
           10.2.4.2 Market Forecast
        10.2.5 Australia
           10.2.5.1 Market Trends
           10.2.5.2 Market Forecast
        10.2.6 Indonesia
           10.2.6.1 Market Trends
           10.2.6.2 Market Forecast
        10.2.7 Others
           10.2.7.1 Market Trends
           10.2.7.2 Market Forecast
    10.3    Europe
        10.3.1 Germany
           10.3.1.1 Market Trends
           10.3.1.2 Market Forecast
        10.3.2 France
           10.3.2.1 Market Trends
           10.3.2.2 Market Forecast
        10.3.3 United Kingdom
           10.3.3.1 Market Trends
           10.3.3.2 Market Forecast
        10.3.4 Italy
           10.3.4.1 Market Trends
           10.3.4.2 Market Forecast
        10.3.5 Spain
           10.3.5.1 Market Trends
           10.3.5.2 Market Forecast
        10.3.6 Russia
           10.3.6.1 Market Trends
           10.3.6.2 Market Forecast
        10.3.7 Others
           10.3.7.1 Market Trends
           10.3.7.2 Market Forecast
    10.4    Latin America
        10.4.1 Brazil
           10.4.1.1 Market Trends
           10.4.1.2 Market Forecast
        10.4.2 Mexico
           10.4.2.1 Market Trends
           10.4.2.2 Market Forecast
        10.4.3 Others
           10.4.3.1 Market Trends
           10.4.3.2 Market Forecast
    10.5    Middle East and Africa
        10.5.1 Market Trends
        10.5.2 Market Breakup by Country
        10.5.3 Market Forecast
11    SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12    Value Chain Analysis
13    Porters Five Forces Analysis

    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14    Price Analysis
15    Competitive Landscape

    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    Abbott Laboratories
           15.3.1.1 Company Overview
           15.3.1.2 Product Portfolio
           15.3.1.3 Financials
           15.3.1.4 SWOT Analysis
        15.3.2    Becton Dickinson and Company
           15.3.2.1 Company Overview
           15.3.2.2 Product Portfolio
           15.3.2.3 Financials
           15.3.2.4 SWOT Analysis
        15.3.3    Coris Bioconcept
           15.3.3.1 Company Overview
           15.3.3.2 Product Portfolio
        15.3.4    Danaher Corporation
           15.3.4.1 Company Overview
           15.3.4.2 Product Portfolio
           15.3.4.3 Financials
           15.3.4.4 SWOT Analysis
        15.3.5    DiaSorin S.p.A.
           15.3.5.1 Company Overview
           15.3.5.2 Product Portfolio
           15.3.5.3 Financials
           15.3.5.4 SWOT Analysis
        15.3.6    F. Hoffmann-La Roche Ltd (Roche Holding AG)
           15.3.6.1 Company Overview
           15.3.6.2 Product Portfolio
           15.3.6.3 SWOT Analysis
        15.3.7    Hologic Inc.
           15.3.7.1 Company Overview
           15.3.7.2 Product Portfolio
           15.3.7.3 Financials
           15.3.7.4 SWOT Analysis
        15.3.8    Meridian Bioscience Inc.
           15.3.8.1 Company Overview
           15.3.8.2 Product Portfolio
           15.3.8.3 Financials
           15.3.8.4 SWOT Analysis
        15.3.9    Qiagen N.V
           15.3.9.1 Company Overview
           15.3.9.2 Product Portfolio
           15.3.9.3 Financials
           15.3.9.4 SWOT Analysis
        15.3.10    Quidel Corporation
           15.3.10.1 Company Overview
           15.3.10.2 Product Portfolio
           15.3.10.3 Financials
           15.3.10.4 SWOT Analysis
        15.3.11    Sekisui Diagnostics LLC (Sekisui Medical Co. Ltd.)
           15.3.11.1 Company Overview
           15.3.11.2 Product Portfolio
        15.3.12    Siemens Healthineers AG (Siemens AG)
           15.3.12.1 Company Overview
           15.3.12.2 Product Portfolio
           15.3.12.3 Financials
           15.3.12.4 SWOT Analysis

List of Figures

Figure 1: Global: Influenza Diagnostics Market: Major Drivers and Challenges
Figure 2: Global: Influenza Diagnostics Market: Sales Value (in Million US$), 2016-2021
Figure 3: Global: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 4: Global: Influenza Diagnostics Market: Breakup by Product (in %), 2021
Figure 5: Global: Influenza Diagnostics Market: Breakup by Test Type (in %), 2021
Figure 6: Global: Influenza Diagnostics Market: Breakup by Type of Flu (in %), 2021
Figure 7: Global: Influenza Diagnostics Market: Breakup by End User (in %), 2021
Figure 8: Global: Influenza Diagnostics Market: Breakup by Region (in %), 2021
Figure 9: Global: Influenza Diagnostics (Test Kit and Reagents) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Influenza Diagnostics (Test Kit and Reagents) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Influenza Diagnostics (Instruments) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Influenza Diagnostics (Instruments) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Influenza Diagnostics (Other Products) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Influenza Diagnostics (Other Products) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Influenza Diagnostics (Molecular Diagnostic Tests) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Influenza Diagnostics (Molecular Diagnostic Tests) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Influenza Diagnostics (Traditional Diagnostic Tests) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Influenza Diagnostics (Traditional Diagnostic Tests) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Influenza Diagnostics (Type A Flu) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Influenza Diagnostics (Type A Flu) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Influenza Diagnostics (Type B Flu) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Influenza Diagnostics (Type B Flu) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Influenza Diagnostics (Type C Flu) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Influenza Diagnostics (Type C Flu) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Influenza Diagnostics (Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Influenza Diagnostics (Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Influenza Diagnostics (Diagnostic Laboratories) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Influenza Diagnostics (Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: Influenza Diagnostics (Other End Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Influenza Diagnostics (Other End Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: North America: Influenza Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: North America: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: United States: Influenza Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: United States: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Canada: Influenza Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Canada: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Asia-Pacific: Influenza Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Asia-Pacific: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: China: Influenza Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: China: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: Japan: Influenza Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: Japan: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: India: Influenza Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: India: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: South Korea: Influenza Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: South Korea: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: Australia: Influenza Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: Australia: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: Indonesia: Influenza Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: Indonesia: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: Others: Influenza Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: Others: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: Europe: Influenza Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: Europe: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: Germany: Influenza Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: Germany: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: France: Influenza Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: France: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: United Kingdom: Influenza Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: United Kingdom: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Italy: Influenza Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Italy: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Spain: Influenza Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: Spain: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Russia: Influenza Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Russia: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: Others: Influenza Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: Others: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: Latin America: Influenza Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: Latin America: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Brazil: Influenza Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Brazil: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Mexico: Influenza Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Mexico: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Others: Influenza Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Others: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Middle East and Africa: Influenza Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 78: Middle East and Africa: Influenza Diagnostics Market: Breakup by Country (in %), 2021
Figure 79: Middle East and Africa: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 80: Global: Influenza Diagnostics Industry: SWOT Analysis
Figure 81: Global: Influenza Diagnostics Industry: Value Chain Analysis
Figure 82: Global: Influenza Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Influenza Diagnostics Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Influenza Diagnostics Market Forecast: Breakup by Product (in Million US$), 2022-2027
Table 3: Global: Influenza Diagnostics Market Forecast: Breakup by Test Type (in Million US$), 2022-2027
Table 4: Global: Influenza Diagnostics Market Forecast: Breakup by Type of Flu (in Million US$), 2022-2027
Table 5: Global: Influenza Diagnostics Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 6: Global: Influenza Diagnostics Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 7: Global: Influenza Diagnostics Market: Competitive Structure
Table 8: Global: Influenza Diagnostics Market: Key Players


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links